Text Size

Mapracorat, a selective glucocorticoid receptor agonist, upregulates RelB, an anti-inflammatory nuclear factor-kappaB protein, in human ocular cells

Spinelli S.L., Xi X., McMillan D.H., Woeller C.F., Richardson M.E., Cavet M.E., Zhang J.-Z., Feldon S.E., Phipps R.P.


  • 2014
  • Experimental Eye Research
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Categories

    Clinical development

  • Affiliations

    Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States; Department of Ophthalmology, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States; University of Rochester School of Medicine and Dentistry, Rochester, NY, United States; Flaum Eye Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States; Global Pharmaceutical R and D, Bausch and Lomb, Inc., Rochester, NY, United States; Department of Pathology, University of Vermont, Burlington, VT, United States; Preclinical Development, Santen Inc., Emeryville, CA, United States

Related Publications

Layer-by-layer tear film measurement in patients with dry eye and meibomian gland dysfunction

Arita R., Takeuchi G., Sasai K., Nakamura M., Akiba M.


Multimodal Approach in Dry Eye Disease Combining In Vivo Confocal Microscopy and HLA-DR Expression

Blautain, B.; Rabut, G.; Dupas, B.; Riancho, L.; Liang, H.; Luzu, J.: Labbé, A.; Garrigue J.-S.; Brignole-Baudouin, F.; Baudouin, C.; Kessal, K.


Trans-eyelid distribution of epinastine to the conjunctiva following eyelid application in rabbits

Mochizuki T.; Hata T.; Mori N.; Yamazaki T.; Noto T.; Mano H.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022